2020 Vision For FDA's Sentinel: 'Systemic' Integration Of Surveillance Looms

PDUFA reauthorization agreement sets up fiscal 2020 as milestone for weaving active surveillance into drug review – and for keeping sponsors informed of activities that affect their products.